Department of Chemistry and the College
Raymond Moellering’s research lies at the interface of chemistry and biology, with an eye toward understanding and intervening in human disease. By integrating chemical synthesis, cell biology, and mass spectrometry platforms, his research aims to identify novel biological mechanisms underlying such metabolic diseases as diabetes and cancer, and to subsequently develop innovative diagnostic and therapeutic modalities to treat these disorders. His primary areas of interest include the role of protein modifications and interaction networks in the regulation of metabolic homeostasis, particularly within the contexts of aging, metabolic disease, and cancer.
Moellering holds numerous patents and has authored publications in a variety of scientific journals, including Nature, Science, and Chemistry & Biology. He received a Centennial Predoctoral Fellowship from the American Association for Cancer Research, the Dale F. Frey Award for Breakthrough Scientists from the Damon Runyon Cancer Research Foundation, and the Pathway to Independence Award from the National Cancer Institute.
Moellering obtained BS degrees in chemistry and biochemistry and molecular biophysics from the University of Arizona, and received his PhD in chemistry and chemical biology from Harvard University. He was most recently a Howard Hughes Medical Institute Damon Runyon Postdoctoral Fellow at the Scripps Research Institute.
Moellering joined the University of Chicago faculty in 2014.